Author Question: After teaching a client receiving leflunomide, the nurse determines that the teaching was successful ... (Read 37 times)

robinn137

  • Hero Member
  • *****
  • Posts: 544
After teaching a client receiving leflunomide, the nurse determines that the teaching was successful when the client identifies which of the following as a possible adverse reaction? Select all that apply.
 
  A) Alopecia
  B) Hypotension
  C) Diarrhea
  D) Nystagmus
  E) Hematuria

Question 2

A nurse would monitor a client closely for increased CNS depressant effects when a skeletal muscle relaxant is used concomitantly with which of the following? Select all that apply.
 
  A) Antihistamine
  B) Oral contraceptives
  C) Alcohol
  D) Opiates
  E) Antidiabetic medications



meganlapinski

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

Ans: A, C
Feedback:
Adverse reactions to leflunomide include hypertension, alopecia, rash, nausea, and diarrhea.

Answer to Question 2

Ans: A, C, D
Feedback:
The concomitant use of skeletal muscle relaxants and antihistamines, alcohol, opiates, or sedatives can result in increased CNS depressant effects.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

The average older adult in the United States takes five prescription drugs per day. Half of these drugs contain a sedative. Alcohol should therefore be avoided by most senior citizens because of the dangerous interactions between alcohol and sedatives.

Did you know?

Of the estimated 2 million heroin users in the United States, 600,000–800,000 are considered hardcore addicts. Heroin addiction is considered to be one of the hardest addictions to recover from.

Did you know?

The average office desk has 400 times more bacteria on it than a toilet.

Did you know?

Intradermal injections are somewhat difficult to correctly administer because the skin layers are so thin that it is easy to accidentally punch through to the deeper subcutaneous layer.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

For a complete list of videos, visit our video library